| Absorption |
| Blood-Brain Barrier | BBB- | 0.5221 |
| Human Intestinal Absorption | HIA- | 0.6438 |
| Caco-2 Permeability | Caco2- | 0.7743 |
| P-glycoprotein Substrate | Non-substrate | 0.6158 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9722 |
| Non-inhibitor | 0.9500 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9231 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8525 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8700 |
| CYP450 2D6 Substrate | Non-substrate | 0.8756 |
| CYP450 3A4 Substrate | Non-substrate | 0.7591 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9069 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9095 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9674 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9381 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9403 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9939 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9568 |
| Non-inhibitor | 0.8843 |
| AMES Toxicity | Non AMES toxic | 0.8933 |
| Carcinogens | Non-carcinogens | 0.8796 |
| Fish Toxicity | High FHMT | 0.8694 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.7915 |
| Honey Bee Toxicity | High HBT | 0.5478 |
| Biodegradation | Ready biodegradable | 0.9145 |
| Acute Oral Toxicity | III | 0.5789 |
| Carcinogenicity (Three-class) | Non-required | 0.7565 |